CN104491039A - 一种用于治疗痛风急性发作的药物组合物及其制备方法和应用 - Google Patents
一种用于治疗痛风急性发作的药物组合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN104491039A CN104491039A CN201410745259.9A CN201410745259A CN104491039A CN 104491039 A CN104491039 A CN 104491039A CN 201410745259 A CN201410745259 A CN 201410745259A CN 104491039 A CN104491039 A CN 104491039A
- Authority
- CN
- China
- Prior art keywords
- pharmaceutical composition
- xinhuangpian
- tincture
- treatment
- gout
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000005569 Gout Diseases 0.000 title claims abstract description 22
- 239000008194 pharmaceutical composition Substances 0.000 title claims abstract description 11
- 230000001154 acute effect Effects 0.000 title claims abstract description 10
- 238000002360 preparation method Methods 0.000 title abstract description 4
- 230000000694 effects Effects 0.000 claims abstract description 23
- 239000003814 drug Substances 0.000 claims abstract description 14
- 229940098465 tincture Drugs 0.000 claims abstract description 13
- 235000012907 honey Nutrition 0.000 claims abstract description 12
- 241000628997 Flos Species 0.000 claims description 10
- 239000011248 coating agent Substances 0.000 claims description 2
- 238000000576 coating method Methods 0.000 claims description 2
- 231100000614 poison Toxicity 0.000 claims description 2
- 231100000957 no side effect Toxicity 0.000 claims 1
- 239000002574 poison Substances 0.000 claims 1
- 238000011282 treatment Methods 0.000 abstract description 30
- 238000002474 experimental method Methods 0.000 abstract description 2
- 241000219784 Sophora Species 0.000 abstract 2
- 239000009291 xinhuang Substances 0.000 abstract 2
- 208000002193 Pain Diseases 0.000 description 10
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 8
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 7
- 229940116269 uric acid Drugs 0.000 description 7
- 230000008961 swelling Effects 0.000 description 6
- IAKHMKGGTNLKSZ-INIZCTEOSA-N (S)-colchicine Chemical compound C1([C@@H](NC(C)=O)CC2)=CC(=O)C(OC)=CC=C1C1=C2C=C(OC)C(OC)=C1OC IAKHMKGGTNLKSZ-INIZCTEOSA-N 0.000 description 4
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 206010018634 Gouty Arthritis Diseases 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 229960001338 colchicine Drugs 0.000 description 2
- 238000011443 conventional therapy Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 210000000878 metatarsophalangeal joint Anatomy 0.000 description 2
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- 235000011837 pasties Nutrition 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical group CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 229940121710 HMGCoA reductase inhibitor Drugs 0.000 description 1
- 201000001431 Hyperuricemia Diseases 0.000 description 1
- 201000009623 Myopathy Diseases 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 206010046337 Urate nephropathy Diseases 0.000 description 1
- 208000026816 acute arthritis Diseases 0.000 description 1
- OFCNXPDARWKPPY-UHFFFAOYSA-N allopurinol Chemical compound OC1=NC=NC2=C1C=NN2 OFCNXPDARWKPPY-UHFFFAOYSA-N 0.000 description 1
- 229960003459 allopurinol Drugs 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- 210000000544 articulatio talocruralis Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000003862 glucocorticoid Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 239000002471 hydroxymethylglutaryl coenzyme A reductase inhibitor Substances 0.000 description 1
- 210000001503 joint Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000000440 neutrophil Anatomy 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 230000026731 phosphorylation Effects 0.000 description 1
- 238000006366 phosphorylation reaction Methods 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003180 prostaglandins Chemical class 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/413—Gall bladder; Bile
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/56—Loganiaceae (Logania family), e.g. trumpetflower or pinkroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Zoology (AREA)
- Insects & Arthropods (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Physiology (AREA)
- Animal Husbandry (AREA)
- Nutrition Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
组别 | n | 治愈 | 有效 | 无效 | 总有效率(%) |
对照组 | 30 | 16 | 7 | 7 | 76.67 |
新癀片治疗组 | 30 | 21* | 5* | 4* | 86.67 |
新黄蜂治疗组 | 30 | 24*# | 5*# | 1*# | 96.67 |
组别 | n | 住院天数 | 红肿消退时间 | VAS 0分时间 |
对照组 | 30 | 3.82±1.16 | 2.84±1.02 | 2.82±2.03 |
新癀片治疗组 | 30 | 5.77±1.73* | 3.41±2.12* | 4.37±1.69* |
新黄蜂治疗组 | 30 | 8.40±3.15*# | 5.85±2.56*# | 6.14±2.83*# |
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410745259.9A CN104491039B (zh) | 2014-12-09 | 2014-12-09 | 一种用于治疗痛风急性发作的药物组合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410745259.9A CN104491039B (zh) | 2014-12-09 | 2014-12-09 | 一种用于治疗痛风急性发作的药物组合物及其制备方法和应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104491039A true CN104491039A (zh) | 2015-04-08 |
CN104491039B CN104491039B (zh) | 2017-07-11 |
Family
ID=52932553
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410745259.9A Active CN104491039B (zh) | 2014-12-09 | 2014-12-09 | 一种用于治疗痛风急性发作的药物组合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104491039B (zh) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198202A (zh) * | 2011-04-25 | 2011-09-28 | 周国生 | 痛风丸 |
-
2014
- 2014-12-09 CN CN201410745259.9A patent/CN104491039B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102198202A (zh) * | 2011-04-25 | 2011-09-28 | 周国生 | 痛风丸 |
Non-Patent Citations (2)
Title |
---|
周涛: "三妙消痛汤加减治疗急性痛风性关节炎31例临床观察", 《中国中西医结合学会周围血管疾病专业委员会周围血管疾病学术会议论文集》 * |
程乐卿: "《偏方验方集锦》", 31 January 2013, 青岛出版社 * |
Also Published As
Publication number | Publication date |
---|---|
CN104491039B (zh) | 2017-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101209267B (zh) | 红色诺卡氏菌细胞壁骨架在制备治疗皮肤损伤和疮疡的药物中的用途 | |
Nakae et al. | Kampo medicines for frailty in locomotor disease | |
CN1327892C (zh) | 外用止痛喷液 | |
CN110876796B (zh) | 一种用于治疗痛风急性发作的中药组合物及其制备方法和应用 | |
CN104095970A (zh) | 一种治疗寻常疣的外敷药酒 | |
CN104491039A (zh) | 一种用于治疗痛风急性发作的药物组合物及其制备方法和应用 | |
CN102357215A (zh) | 一种治疗急、慢性胆囊炎导致的右胁胀满、疼痛的药膏 | |
CN102846750B (zh) | 风痛宁复合制剂及其制备方法 | |
CN111991471A (zh) | 一种治疗刀伤、创伤、烧烫伤的外用中药制剂及其制备方法 | |
CN105288059A (zh) | 一种治疗腕部骨折后关节僵硬的中药熏洗剂 | |
CN104398910B (zh) | 一种用于治疗滑膜炎的中药制剂 | |
CN108619427A (zh) | 一种预防治疗痛风性关节炎的祛痛降酸药茶 | |
Bakhshi et al. | Prospective, open label study of Euphorbia prostrata extract 100 mg in the treatment of bleeding haemorrhoids | |
CN113491739B (zh) | 治疗子宫内膜异位症的止痛消癥散结中药及其制作方法 | |
CN104147216B (zh) | 一种治疗胸壁结核的中药组合物 | |
CN101190284A (zh) | 一种治疗急性阴囊湿疹的外洗药物 | |
CN106039113A (zh) | 一种用于治疗痛风的中药组方 | |
CN102784201B (zh) | 一种治疗结块无头型暑疖的糊状药物 | |
CN104491799B (zh) | 一种用于贴敷治疗类风湿关节炎的中药散剂 | |
CN104784332B (zh) | 一种治疗慢性尿路感染的药剂的制备方法 | |
CN103919869A (zh) | 一种治疗肛周脓肿的中药组合物 | |
CN103479917B (zh) | 一种治疗烧烫伤的中药组合物 | |
CN106822657A (zh) | 一种预防根治肾病的中草药 | |
CN111939196A (zh) | 一种缓解痛风的精油止痛膏 | |
CN118078896A (zh) | 一种辅助治疗内痔的中药熏洗剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information | ||
CB03 | Change of inventor or designer information |
Inventor after: Xiong Weijian Inventor after: Zhang Qi Inventor after: Yu Xiao Inventor after: Ren Dewei Inventor after: Lei Lei Inventor after: Xiong Yanying Inventor after: Liu Chengxuan Inventor after: Luo Yan Inventor after: Long Mei Inventor after: Ren Jing Inventor after: Li Ying Inventor after: Zhong Jin Inventor after: Yang Jing Inventor after: Li Fan Inventor after: Zhang Ling Inventor after: Zheng Jin Inventor after: OUYANG XIAOQIN Inventor after: Liu Hong Inventor before: Li Ying Inventor before: Xiong Weijian Inventor before: Zhong Jin Inventor before: Liu Chengxuan Inventor before: Yu Xiao Inventor before: OUYANG XIAOQIN Inventor before: Yang Jing |
|
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20170601 Address after: 400021 Chongqing Jiangbei Panxi seven branch No. 6 Applicant after: Chongqing Hospital of Traditional Chinese Medicine Address before: 400021 Chongqing Hospital of traditional Chinese medicine, Jiangbei District, Chongqing Applicant before: Li Ying Applicant before: Xiong Weijian Applicant before: Zhong Jin |
|
GR01 | Patent grant | ||
GR01 | Patent grant |